Back to search

Comparative Safety and Tolerability of Clopidogrel and Aspirin

Data up to Jan 2025

Published1999
Citations159
References24

Total Citations Per Year

Abstract

References (24)

Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs

1971 • 8,596 citations

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

1996 • 6,350 citations

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1997 • 4,490 citations

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

1994 • 3,408 citations

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1996 • 2,812 citations

European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

1997 • 1,389 citations

A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients

1989 • 1,209 citations

Cytoprotection by prostaglandins

1979 • 1,076 citations

A Critical Analysis

1995 • 671 citations

The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction

1990 • 651 citations

Prophylactic aspirin and risk of peptic ulcer bleeding

1995 • 578 citations

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

1994 • 566 citations

Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases

1998 • 428 citations

Incidence and Clinical Course of Thrombotic Thrombocytopenic Purpura Due to Ticlopidine Following Coronary Stenting

1999 • 235 citations

Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial.

1995 • 134 citations

RISKS OF LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTION

1982 • 71 citations

Aplastic anaemia

1995 • 55 citations

Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group.

1994 • 38 citations

An Analysis of the Side Effects of Ticlopidine

1993 • 27 citations

Efficacy and safety of different aspirin dosages on vascular diseases in high-risk patients. A metaregression analysis.

1995 • 25 citations

Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Second report of the Sixty Plus Reinfarction Study Research Group.

1982 • 22 citations

Clopidogrel and antiplatelet therapy

1994 • 21 citations

Antithrombotic therapies for stroke prevention

1994 • 18 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...